International Stem Cell Corporation (ISCO)
|Net Income (ttm)||-2.72M|
|Trading Day||May 4|
|Day's Range||0.5000 - 0.5500|
|52-Week Range||0.3000 - 1.0800|
There are no news available yet.
International Stem Cell Corporation focuses on the development of therapeutic and biomedical products worldwide. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; liver cells to treat various congenital and acquired liver diseases; and islet cells for the treatment of diabetes. The company also develops, manufactures, and markets skincare... [Read more...]
|Stock Exchange |
|Ticker Symbol |
In 2020, ISCO's revenue was $7.13 million, a decrease of -24.75% compared to the previous year's $9.47 million. Losses were -$2.72 million, -36.13% less than in 2019.
The average 12-month stock price forecast for ISCO is 0.54, which is a decrease of -1.82% from the latest price.